References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596

Aydogan U, Aydogdu A, Akbulut H, et al. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J. 2012;59(12):1099-1105.

Ballester Ferré MP, Boscá-Watts MM, Mínguez Pérez M. Crohn's disease. Enfermedad de Crohn. Med Clin (Barc). 2018;151(1):26-33.

Bičíková M, Dušková M, Vítků J, et al. Vitamin D in anxiety and affective disorders. Physiol Res. 2015;64(Suppl 2):S101-S103.

Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048-1079.

Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep. 2016;18(11):101.

Cleveland Clinic. (2022, June 1). Separation Anxiety. https://my.clevelandclinic.org/health/diseases/23142-separation-anxiety.

Davies RD, Gabbert SL, Riggs PD. Anxiety Disorders in Neurologic Illness. Curr Treat Options Neurol. 2001;3(4):333-346

Del Giacco SR, Cappai A, Gambula L, et al. The asthma-anxiety connection. Respir Med. 2016;120:44-53.

Encyclopedia Britannica. (2023, May 26). Hippocampus. The Editors of Encyclopedia Britannica. https://www.britannica.com/science/hippocampus.

Experimental and clinical psychopharmacology, 18(2), 129–134. https://doi.org/10.1037/a0019022

Ferber, S. G., Hazani, R., Shoval, G., & Weller, A. (2021). Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives. Current neuropharmacology, 19(3), 360–371. https://doi.org/10.2174/1570159X18666200429234430

Gessl A, Lemmens-Gruber R, Kautzky-Willer A. Thyroid disorders. Handb Exp Pharmacol. 2012;(214):361-386.

Girndt M. Störungen des Elektrolytstoffwechsels [Electrolyte disorders]. Internist (Berl). 2011;52(8):963-975.

Gorman JM, Martinez JM, Liebowitz MR, Fyer AJ, Klein DF. Hypoglycemia and panic attacks. Am J Psychiatry. 1984;141(1):101-102.

Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6S.

Huecker MR, Bhutta BS, Dominique E. Adrenal Insufficiency. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 31, 2022.

Huestis M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & biodiversity, 4(8), 1770–1804. https://doi.org/10.1002/cbdv.200790152

Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736-747.

Kikuchi M, Komuro R, Oka H, Kidani T, Hanaoka A, Koshino Y. Relationship between anxiety and thyroid function in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(1):77-81.

Laganà AS, La Rosa VL, Rapisarda AMC, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:323-330. Published 2017 May 16.

Lin TY, Hedrick RM, Ishak WW. Panic Attacks in HYPERALDOSTERONISM. Innov Clin Neurosci. 2019;16(3-4):19-21.

Moon HS, Lee SK, Chung JH, In CB. Hypocalcemia and hypokalemia due to hyperventilation syndrome in spinal anesthesia -A case report-. Korean J Anesthesiol. 2011;61(6):519-523.

National Institute of Mental Health. Any Anxiety Disorder. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder

Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011;31(7):1183-1191.

Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and cannabinoid research, 1(1), 44–46. https://doi.org/10.1089/can.2015.29003.ebr

Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783-800.

Patel N, Shackelford K. Irritable Bowel Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 30, 2022.

Pennypacker, S. D., Cunnane, K., Cash, M. C., & Romero-Sandoval, E. A. (2022). Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot. Frontiers in pharmacology, 13, 921493. https://doi.org/10.3389/fphar.2022.921493

Rivas AM, Mulkey Z, Lado-Abeal J, Yarbrough S. Diagnosing and managing low serum testosterone. Proc (Bayl Univ Med Cent). 2014;27(4):321-324.

Sapra A, Bhandari P. Diabetes Mellitus. In: StatPearls. Treasure Island (FL): StatPearls Publishing; June 26, 2022.

Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of translational medicine, 18(1), 374. https://doi.org/10.1186/s12967-020-02518-2

Stopeck AT. Women's health: the struggle to restore hormonal balance [published correction appears in Am J Med. 2006 Feb;119(2):191]. Am J Med. 2005;118(11):1181-1182.

Su VY, Chen YT, Lin WC, et al. Sleep Apnea and Risk of Panic Disorder. Ann Fam Med. 2015;13(4):325-330.

Walden R, Tomlinson B. Cardiovascular Disease. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011.

Zou, S., & Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International journal of molecular sciences, 19(3), 833. https://doi.org/10.3390/ijms19030833

Zvolensky, M. J., Cougle, J. R., Johnson, K. A., Bonn-Miller, M. O., & Bernstein, A. (2010). Marijuana use and panic psychopathology among a representative sample of adults. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917792/